Literature DB >> 2672272

Evidence for activation of platelets in the synovial fluid from patients with rheumatoid arthritis.

G K Endresen1.   

Abstract

Platelets were isolated by gel filtration from paired samples of peripheral blood and synovial fluid (SF) aspirated from inflamed knee joints from 20 adult patients with rheumatoid arthritis (RA) as well as from peripheral blood obtained from 20 healthy subjects. The platelets from the three different sources were investigated for quantitative differences in the number of two distinct types of intracellular storage organelles using immunofluorescence staining for platelet factor 4 (PF4) and labelling with the fluorescent substance mepacrine (MC). The number of PF4-stained organelles per cell was the same in the peripheral normal and RA platelets. This number was distinctly lower in the SF platelets. The peripheral and SF platelets from the RA patients had the same number of MC-labelled organelles. This number was distinctly lower than in the normal cells. The results suggest that the peripheral RA platelets had been activated to liberate serotonin and other substances from one type of organelles, and that the SF platelets had been activated to an additional liberation of PF4 from another such type. Liberated PF4, serotonin, and other substances from SF platelets may, in several ways, contribute to the inflammatory responses of RA.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2672272     DOI: 10.1007/bf00270285

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN: 0172-8172            Impact factor:   2.631


  26 in total

1.  1958 Revision of diagnostic criteria for rheumatoid arthritis.

Authors:  M W ROPES; G A BENNETT; S COBB; R JACOX; R A JESSAR
Journal:  Bull Rheum Dis       Date:  1958-12

2.  The mechanism of thrombin-induced platelet factor 4 secretion.

Authors:  M H Ginsberg; L Taylor; R G Painter
Journal:  Blood       Date:  1980-04       Impact factor: 22.113

3.  Sulphinpyrazone and indomethacin for inhibition of platelet prostaglandin synthesis.

Authors:  P C Huijgens; C A van den Berg; L M Imandt; M M Langenhuijsen
Journal:  Thromb Res       Date:  1981-11-01       Impact factor: 3.944

4.  Platelets in the synovial space.

Authors:  M H Ginsberg; G Breth; J L Skosey
Journal:  Arthritis Rheum       Date:  1978 Nov-Dec

5.  Platelet-activating activity in synovial fluids of patients with rheumatoid arthritis, juvenile rheumatoid arthritis, gout, and noninflammatory arthropathies.

Authors:  C Shapleigh; F H Valone; P H Schur; E J Goetzl; K F Austen
Journal:  Arthritis Rheum       Date:  1980-07

6.  Platelets in synovial fluid.

Authors:  M Yaron; M Djaldetti
Journal:  Arthritis Rheum       Date:  1978-06

7.  Platelet serotonin release in rheumatoid arthritis: a study in food-intolerant patients.

Authors:  C H Little; A G Stewart; M R Fennessy
Journal:  Lancet       Date:  1983-08-06       Impact factor: 79.321

8.  Comparative investigation on the influence of human and bovine collagen types I, II and III on the aggregation of human platelets.

Authors:  L Balleisen; S Gay; R Marx; K Kühn
Journal:  Klin Wochenschr       Date:  1975-10-01

9.  Serotonin content of platelets in inflammatory rheumatic diseases. Correlation with clinical activity.

Authors:  J Zeller; E Weissbarth; B Baruth; H Mielke; H Deicher
Journal:  Arthritis Rheum       Date:  1983-04

10.  SOluble and insoluble immune complex-platelet interactions in rheumatoid inflammation.

Authors:  R P Yeatts; R Turner; R Collins; J Kaufmann; H Mashburn
Journal:  Ann Rheum Dis       Date:  1978-10       Impact factor: 19.103

View more
  12 in total

Review 1.  Adhesion molecules in rheumatoid arthritis.

Authors:  N Oppenheimer-Marks; P E Lipsky
Journal:  Springer Semin Immunopathol       Date:  1998

Review 2.  Platelet function in rheumatoid arthritis: arthritic and cardiovascular implications.

Authors:  Armen Yuri Gasparyan; Antonios Stavropoulos-Kalinoglou; Dimitri P Mikhailidis; Karen M J Douglas; George D Kitas
Journal:  Rheumatol Int       Date:  2011-02       Impact factor: 2.631

Review 3.  Sphingosine 1-phosphate receptor-targeted therapeutics in rheumatic diseases.

Authors:  Nathalie Burg; Jane E Salmon; Timothy Hla
Journal:  Nat Rev Rheumatol       Date:  2022-05-04       Impact factor: 20.543

4.  Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.

Authors:  C Trocmé; H Marotte; A Baillet; B Pallot-Prades; J Garin; L Grange; P Miossec; J Tebib; F Berger; M J Nissen; R Juvin; F Morel; P Gaudin
Journal:  Ann Rheum Dis       Date:  2008-07-29       Impact factor: 19.103

Review 5.  Platelets: active players in the pathogenesis of arthritis and SLE.

Authors:  Eric Boilard; Patrick Blanco; Peter A Nigrovic
Journal:  Nat Rev Rheumatol       Date:  2012-08-07       Impact factor: 20.543

Review 6.  Pathologic thrombopoiesis of rheumatoid arthritis.

Authors:  Ihsan Ertenli; Sedat Kiraz; M Akif Oztürk; Ibrahim c Haznedaroğlu; Ismail Celik; Meral Calgüneri
Journal:  Rheumatol Int       Date:  2003-02-11       Impact factor: 2.631

Review 7.  Novel uses for anti-platelet agents as anti-inflammatory drugs.

Authors:  S C Pitchford
Journal:  Br J Pharmacol       Date:  2007-07-02       Impact factor: 8.739

8.  Temporomandibular joint bone tissue resorption in patients with early rheumatoid arthritis can be predicted by joint crepitus and plasma glutamate level.

Authors:  Anna-Kari Hajati; Karin Näsström; Per Alstergren; Johan Bratt; Sigvard Kopp
Journal:  Mediators Inflamm       Date:  2010-06-29       Impact factor: 4.711

9.  Influence of serotonin on the analgesic effect of granisetron on temporomandibular joint arthritis.

Authors:  Ulle Voog; Per Alstergren; Edvitar Leibur; Riina Kallikorm; Sigvard Kopp
Journal:  Mediators Inflamm       Date:  2004-12       Impact factor: 4.711

10.  Blood serotonin and joint pain in seropositive versus seronegative rheumatoid arthritis.

Authors:  Sigvard Kopp; Per Alstergren
Journal:  Mediators Inflamm       Date:  2002-08       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.